Fingerprint
Dive into the research topics of 'Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial
Susan B. Bressler, Abhijit Barve, Prasanna C. Ganapathi, Katrin Beckmann, Rajendra S. Apte, Dennis M. Marcus, Kristine Baumane, Somesh Agarwal, Piotr Oleksy, David A. Reichstein, Sunil S. Patel, Jan Ernest, Rozsa Dégi, Vishali Gupta, Genichiro Kishino, Motohiro Kamei, Subramanian Loganathan
- Department of Ophthalmology and Visual Sciences
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Neurosciences
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Center of Regenerative Medicine
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations